<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5B71FE8A-DC4E-41C4-81D2-E6D6A7AA0318"><gtr:id>5B71FE8A-DC4E-41C4-81D2-E6D6A7AA0318</gtr:id><gtr:name>Astex Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5B71FE8A-DC4E-41C4-81D2-E6D6A7AA0318"><gtr:id>5B71FE8A-DC4E-41C4-81D2-E6D6A7AA0318</gtr:id><gtr:name>Astex Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/04B6A2AB-0C99-425B-98F3-5F2CDFF2D434"><gtr:id>04B6A2AB-0C99-425B-98F3-5F2CDFF2D434</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:surname>Noble</gtr:surname><gtr:orcidId>0000-0002-3060-3772</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/39A367CA-12EE-4913-85A1-7C27976C496B"><gtr:id>39A367CA-12EE-4913-85A1-7C27976C496B</gtr:id><gtr:firstName>Alastair</gtr:firstName><gtr:otherNames>M</gtr:otherNames><gtr:surname>Buchan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/95DF1C05-09A0-412A-87F2-6D0A6175BFD7"><gtr:id>95DF1C05-09A0-412A-87F2-6D0A6175BFD7</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0549AE03-83A7-456B-B9EC-6790271B75F3"><gtr:id>0549AE03-83A7-456B-B9EC-6790271B75F3</gtr:id><gtr:firstName>Chas</gtr:firstName><gtr:surname>Bountra</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CF74B8C4-3225-4D0E-B74A-C21D1CC10B5B"><gtr:id>CF74B8C4-3225-4D0E-B74A-C21D1CC10B5B</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Brouard</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AE7C12E7-0A2F-4387-B254-0162D531A23E"><gtr:id>AE7C12E7-0A2F-4387-B254-0162D531A23E</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Samson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/65AB0A9D-E8A0-458C-92B9-E13CEDF1726D"><gtr:id>65AB0A9D-E8A0-458C-92B9-E13CEDF1726D</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Hobbs</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/58F614CA-2977-4BDA-9F2D-436188C64CF0"><gtr:id>58F614CA-2977-4BDA-9F2D-436188C64CF0</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Bell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AB9A1DD7-6E64-4042-9440-5CA9F064300A"><gtr:id>AB9A1DD7-6E64-4042-9440-5CA9F064300A</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>Geddes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/125B6E81-3FE3-470D-B4DA-705FCD322D92"><gtr:id>125B6E81-3FE3-470D-B4DA-705FCD322D92</gtr:id><gtr:firstName>Georg</gtr:firstName><gtr:otherNames>Andreas</gtr:otherNames><gtr:surname>Holl?nder</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A2BC6D31-BC0E-4ABE-B6E0-2D94708C3A1F"><gtr:id>A2BC6D31-BC0E-4ABE-B6E0-2D94708C3A1F</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>Alistair</gtr:otherNames><gtr:surname>Robbins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9D846A83-DFE6-4AF2-A9E7-BA990B0931EE"><gtr:id>9D846A83-DFE6-4AF2-A9E7-BA990B0931EE</gtr:id><gtr:firstName>N</gtr:firstName><gtr:surname>Emptage</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/442E2171-F83D-4A44-9BD3-F583D123AA0E"><gtr:id>442E2171-F83D-4A44-9BD3-F583D123AA0E</gtr:id><gtr:firstName>Hugh</gtr:firstName><gtr:otherNames>Christian</gtr:otherNames><gtr:surname>Watkins</gtr:surname><gtr:orcidId>0000-0002-5287-9016</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2C32BD53-810D-456C-8D78-33AF23232E95"><gtr:id>2C32BD53-810D-456C-8D78-33AF23232E95</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Kennedy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D7E9C1F0-D945-4C6E-A909-C32B3F6AAF99"><gtr:id>D7E9C1F0-D945-4C6E-A909-C32B3F6AAF99</gtr:id><gtr:firstName>Donal</gtr:firstName><gtr:otherNames>Donat</gtr:otherNames><gtr:surname>Bradley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5AF2C92C-4DF1-427B-BB41-2C82450D6B36"><gtr:id>5AF2C92C-4DF1-427B-BB41-2C82450D6B36</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Carr</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/80B6FB18-511C-4377-883B-4989FBE79A2D"><gtr:id>80B6FB18-511C-4377-883B-4989FBE79A2D</gtr:id><gtr:firstName>Freddie</gtr:firstName><gtr:surname>Hamdy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A902DB7E-5D05-49BC-BCD5-901CA428016D"><gtr:id>A902DB7E-5D05-49BC-BCD5-901CA428016D</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Ratcliffe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/000EA2B7-E296-4D75-B9A5-8E35AAEEEF42"><gtr:id>000EA2B7-E296-4D75-B9A5-8E35AAEEEF42</gtr:id><gtr:firstName>Lionel</gtr:firstName><gtr:surname>Tarassenko</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/434630DA-F0E3-406B-B4DA-87FBDEF552FD"><gtr:id>434630DA-F0E3-406B-B4DA-87FBDEF552FD</gtr:id><gtr:firstName>Keith</gtr:firstName><gtr:surname>Channon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C3A08924-3211-47F9-A709-DC28DAD85A96"><gtr:id>C3A08924-3211-47F9-A709-DC28DAD85A96</gtr:id><gtr:firstName>Rory</gtr:firstName><gtr:surname>Collins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A536DD0C-05E7-4DCE-899C-25B41BFA1DBB"><gtr:id>A536DD0C-05E7-4DCE-899C-25B41BFA1DBB</gtr:id><gtr:firstName>Glyn</gtr:firstName><gtr:surname>Humphreys</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1697E489-7385-4E68-84DC-C4D5761AC3E1"><gtr:id>1697E489-7385-4E68-84DC-C4D5761AC3E1</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Kennard</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15060"><gtr:id>0C64F15D-BC46-4DB8-96BB-43EF99949594</gtr:id><gtr:title>Oxford Proximity to Discovery Scheme ? Round 2</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15060</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The MRC Proximity to Discovery scheme awards universities funds to help develop new collaborations, and ways of exchanging knowledge and skills.&amp;nbsp; The awards can be used to support activities that promote the value of academic-industry partnership, and enhance academic and industry researchers? understanding of each other?s needs and capabilities.&amp;nbsp; This may be through people exchanges, creation of technology demonstrators, showcase events, commercialisation workshops and ?entrepreneurs in residence? schemes.&amp;nbsp; Such exchanges of knowledge and skills will boost the most fruitful collaborations between UK universities and life science companies.</gtr:technicalSummary><gtr:fund><gtr:end>2017-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>150000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Collaboration with Novartis Basel</gtr:description><gtr:id>2DBE8121-1F85-4829-B54B-872106BEF977</gtr:id><gtr:impact>Cryo electron miscroscopy data collected - analysis of data is ongoing</gtr:impact><gtr:outcomeId>58c97a0675d482.73381802-1</gtr:outcomeId><gtr:partnerContribution>Both companies provided time on their own Titan Krios</gtr:partnerContribution><gtr:piContribution>Both of these collaborations are around exchange of expertise in cryo-electron miscroscopy for access to Titan Krios time for collection of our own samples.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Astex Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Astex Therapeutics Ltd</gtr:department><gtr:description>Collaboration with Novartis Basel</gtr:description><gtr:id>D2FADA22-D863-41F5-8256-E13141BE3882</gtr:id><gtr:impact>Cryo electron miscroscopy data collected - analysis of data is ongoing</gtr:impact><gtr:outcomeId>58c97a0675d482.73381802-2</gtr:outcomeId><gtr:partnerContribution>Both companies provided time on their own Titan Krios</gtr:partnerContribution><gtr:piContribution>Both of these collaborations are around exchange of expertise in cryo-electron miscroscopy for access to Titan Krios time for collection of our own samples.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Health Technology for Tomorrow seminar series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>74041262-522F-4C32-A997-1537A35F48A9</gtr:id><gtr:impact>The Diagnostic Evidence Co-operative Oxford is currently hosting a new series of seminars to showcase and discuss exciting healthcare technology innovations in three key areas, namely wearables, imaging, and digital health-related technologies. The seminars are providing a platform for visitors from the health technology industry to present their ideas and products to a multidisciplinary group of healthcare researchers and members of the wider University community.

The aim of the seminars is to elicit discussions to define priority areas of clinical need and greatest impact for emerging technologies and to foster relationships between academia and industry. These meetings take the format of technology presentations by industry followed by discussions amongst a panel of technology-appropriate specialists before wider discussions with all participants. Seminars either conclude with a networking lunch, or are preceded by networking refreshments.

To date the seminars have covered a wearable patient monitoring device (Isansys) and a digital aid to support antimicrobial prescription in primary care (accuRx). Both seminars stimulated robust discussions and led to follow-up conversations between the visitors from industry and members of academic staff at the University. The DEC has agreed to work with accuRx to evaluate the efficacy of their digital aid for antimicrobial prescription in primary care.

Future Health Technology seminars are planned, with the next taking place at the Society for Academic Primary Care (Southwest region) conference in Oxford on the 23rd of March.</gtr:impact><gtr:outcomeId>58c6a76ca579f0.23248190</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.oxford.dec.nihr.ac.uk/courses-and-events/htt-seminar-3</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diagnostic Evidence Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3D2F80D5-D4CE-4B3B-9D29-E744CAF9866E</gtr:id><gtr:impact>The Diagnostic Evidence Workshop is a two-day training course organised by the Diagnostic Evidence Co-operative Oxford which covers diagnostic test development, evaluation and regulation. The workshop is aimed at diagnostics professionals working in industry, academia, research funding and regulatory affairs. The P2D award provided a number of fully funded places on the course to representatives from small and medium sized enterprises who would otherwise have been unable to attend.</gtr:impact><gtr:outcomeId>58c6a36e78f700.81520827</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Antimicrobial Resistance: Diagnostic Solutions workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C3C2CFDD-1172-4006-B102-8F8BA2A5F250</gtr:id><gtr:impact>The NIHR Diagnostic Evidence Co-operative (DEC) Oxford (Department of Primary Care), with the support of DEC Leeds and the Knowledge Transfer Network, hosted a clinician/industry workshop on diagnostic solutions for antimicrobial resistance (AMR) at St Hugh's College Oxford. Clinicians outlined the clinical need for AMR-relevant diagnostic tests, limitations of available tests and barriers to implementation. Representatives from the diagnostics industry presented new approaches and technologies which are currently in the development pipeline. Oral presentations were followed by rotating workshops covering respiratory tract infections, urinary tract infections, and sepsis. The meeting concluded with a networking dinner in college.</gtr:impact><gtr:outcomeId>58c6a0d7b63d05.94378118</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.oxford.dec.nihr.ac.uk/reports-and-resources/amr-workshop-2017</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DE0511B4-8A50-4755-84F0-DCCF5ABA0036</gtr:id><gtr:title>Severe infections emerge from commensal bacteria by adaptive evolution.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0110a66ba0ae8f1bd3dcd299b4b8e9c"><gtr:id>f0110a66ba0ae8f1bd3dcd299b4b8e9c</gtr:id><gtr:otherNames>Young BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5a6f3077ad1202.63223381</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15060</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>